Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats - Tian, J; Zhang, M; Suo, M (J Cell Mol Med, 2021)